Bixiye
QP31-21 Update for New to Market Medical Drugs: Avalglucosidase Alfa and Selexipag (Uptravi intravenous formulation)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Natiijooyinka Raadinta
Soo bandhiga 2281 - 2290 ee natiijooyinka 4139
Bixiye
QP28-21 Commercial Pharmacy Benefit Exclusion for Select Medications and Formulary Alternatives
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
P5R2-21 New Reimbursement Policy: Outpatient Services Prior to an Inpatient Admission
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P18-21 New Reimbursement Policy for Minnesota Health Care Programs Modifier 90: Reference (Outside) Laboratory and Pass-Through Billing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P11R1-21 UPDATE: Updated Preadmission Services for Inpatient Stays Reimbursement Policy for Minnesota Health Care Programs Members
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P19-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P16-21 Genetic/Molecular Lab Test Coding Reimbursement Policy for MHCP
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
2021 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021